Editorial: Evidence-based approaches in aging and public health.
作者信息
Sathian Brijesh, van Teijlingen Edwin, Simkhada Padam, Kabir Russell, Al Hamad Hanadi
机构信息
Geriatrics and Long Term Care Department, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, United Kingdom.
出版信息
Front Public Health. 2024 Apr 4;12:1391432. doi: 10.3389/fpubh.2024.1391432. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Evidence-based approaches in aging and public health.社论：衰老与公共卫生中的循证方法。
Front Public Health. 2024 Apr 4;12:1391432. doi: 10.3389/fpubh.2024.1391432. eCollection 2024.
2
Evaluating the effectiveness of public health interventions: the role and activities of the Cochrane Collaboration.评估公共卫生干预措施的有效性：Cochrane协作网的作用与活动。
J Epidemiol Community Health. 2006 Apr;60(4):285-9. doi: 10.1136/jech.2003.015354.
3
The Cochrane collaboration as key player in the struggle for better and more relevant patients- and system-oriented research.科克伦协作组织作为争取更好、更相关的以患者和系统为导向的研究的关键参与者。
Epidemiol Psychiatr Sci. 2011 Sep;20(3):225-30. doi: 10.1017/s2045796011000424.
4
[The place and role of evidence-based medicine and health economics in public health].[循证医学与卫生经济学在公共卫生中的地位和作用]
Ann Acad Med Stetin. 2005;51 Suppl 1:29-33.
5
[Info-congress. The Cochrane collaboration, a key role in evidence-based medicine].[信息大会。Cochrane协作网在循证医学中发挥关键作用]
Rev Med Liege. 2001 Nov;56(11):796-8.
6
Achievements and Limitations of Evidence-Based Medicine.循证医学的成就与局限。
J Am Coll Cardiol. 2016 Jul 12;68(2):204-13. doi: 10.1016/j.jacc.2016.03.600.
7
[What is evidence-based public health?].[什么是循证公共卫生？]
Rev Salud Publica (Bogota). 2003 Jan-Apr;5(1):40-5.
8
Review paper: epidemiology, evidence-based medicine, and public health.综述论文：流行病学、循证医学与公共卫生。
Asia Pac J Public Health. 2009 Jul;21(3):244-51. doi: 10.1177/1010539509335516. Epub 2009 May 14.
9
The case for using mixed methods for designing, implementing, and disseminating evidence-based interventions for public health practice.为公共卫生实践设计、实施和传播基于证据的干预措施而使用混合方法的理由。
J Public Health Policy. 2022 Jun;43(2):292-303. doi: 10.1057/s41271-022-00343-z. Epub 2022 Mar 23.
10
The use of public health approaches in mental health programmes.
Int Clin Psychopharmacol. 1999 Jun;14 Suppl 3:S1-5. doi: 10.1097/00004850-199906003-00001.
本文引用的文献
1
The next generation of evidence-based medicine.循证医学的下一代。
Nat Med. 2023 Jan;29(1):49-58. doi: 10.1038/s41591-022-02160-z. Epub 2023 Jan 16.
2
Hallmarks of aging: An expanding universe.衰老的特征：一个不断扩大的领域。
Cell. 2023 Jan 19;186(2):243-278. doi: 10.1016/j.cell.2022.11.001. Epub 2023 Jan 3.
3
Clinical trial design in the era of precision medicine.精准医学时代的临床试验设计。
Genome Med. 2022 Aug 31;14(1):101. doi: 10.1186/s13073-022-01102-1.
4
Late-life learning and health: challenges, opportunities, and future directions.老年学习与健康：挑战、机遇及未来方向
Lancet Healthy Longev. 2021 Oct;2(10):e613-e614. doi: 10.1016/S2666-7568(21)00207-5.
5
Creating efficiencies in the extraction of data from randomized trials: a prospective evaluation of a machine learning and text mining tool.从随机试验中提取数据的效率提升：机器学习和文本挖掘工具的前瞻性评估。
BMC Med Res Methodol. 2021 Aug 16;21(1):169. doi: 10.1186/s12874-021-01354-2.
6
How to Design AI-Driven Clinical Trials in Nuclear Medicine.如何设计核医学中的人工智能驱动临床试验。
Semin Nucl Med. 2021 Mar;51(2):112-119. doi: 10.1053/j.semnuclmed.2020.09.003. Epub 2020 Oct 17.
7
Artificial Intelligence for Clinical Trial Design.人工智能在临床试验设计中的应用。
Trends Pharmacol Sci. 2019 Aug;40(8):577-591. doi: 10.1016/j.tips.2019.05.005. Epub 2019 Jul 17.
8
The Missing Pieces of Artificial Intelligence in Medicine.人工智能在医学中的缺失环节。
Trends Pharmacol Sci. 2019 Aug;40(8):555-564. doi: 10.1016/j.tips.2019.06.001. Epub 2019 Jul 2.
9
How artificial intelligence could redefine clinical trials in cardiovascular medicine: lessons learned from oncology.人工智能如何重新定义心血管医学临床试验：从肿瘤学中汲取的经验教训。
Per Med. 2019 Mar;16(2):83-88. doi: 10.2217/pme-2018-0130. Epub 2019 Mar 6.
Zotero 插件